Behind the Pick

Behind the Pick: Phoenix PharmaLabs

Behind the Pick: Phoenix PharmaLabs

You’re running out of time to invest in Phoenix PharmaLabs. The startup, which is creating the world’s first nonaddictive opioid, closes its raise on Netcapital on March 30.

First Stage Investor Co-Founder Andy Gordon recommended you invest in Phoenix PharmaLabs back in January. This week, we take you Behind the Pick and talk about…

  • Why we really like Phoenix PharmaLabs’ team
  • The X-factor that convinced Andy to add Phoenix PharmaLabs to the First Stage Investor portfolio
  • Just how we discovered Phoenix PharmaLabs in the first place.

Click here to read Andy’s original recommendation.

You still have a few days left to invest in Phoenix PharmaLabs. Just go to the Phoenix PharmaLabs page on Netcapital and click on the gold “Invest” button (you’ll need to create a Netcapital account if you don’t already have one).

The minimum investment is just $0.81. That’s quite the bargain for a drug that could end the opioid epidemic.

Top Posts on Early Investing